FindTrial
Sign In

To check how well nasya and nasya followed by sthanika abhyanga works in improving shoulder pain

A COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF NASYA KARMA WITH MAHAMASHA TAILA AND THE COMBINED EFFICACY OF NASYA KARMA FOLLOWED BY STHANIKA ABHYANGA WITH MAHAMASHA TAILA IN THE MANAGEMENT OF AVABAHUKA W S R TO FROZEN SHOULDER - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106031
Enrollment
40
Registered
2026-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M256- Stiffness of joint, not elsewhereclassified

Interventions

None listed

Sponsors

Dr sukruta M M
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering from avabahuka having classical signs and symptoms such as bahupraspanditahara,amsa sthabdatha,amsa sandhi shoola,bahushosha, patients fit for nasya and sthanika abhyanga

Exclusion criteria

Exclusion criteria: Patients with the history of fracture and dislocation of shoulder joint, any other systemic disorders, uncontrolled diabetes mellitus, pregnant women and lactating mothers, those who are anarha for nasya and sthanika abhyanga

Design outcomes

Primary

MeasureTime frame
Improved in clinical symptoms subjective and objective bahupraspanditahara, sthabdatha, bahushosha, sandhi shoola in amsaTimepoint: Improved in clinical symptoms subjective and objective bahupraspanditahara, sthabdatha, bahushosha, sandhi shoola in amsa—

Secondary

MeasureTime frame
Improvement in overall signs and symptoms of avabahukaTimepoint: Patients will be assessed on 0th 7th 14th 21st final assessment on 30th day—

Countries

India

Contacts

Public ContactDr kavita Bhadri

Rajiv Gandhi University Bangalore

kavitabhadri@gmail.com9480211065

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026